Abstract Background The Valve Academic Research Consortium 3 (VARC‐3) standardizes the classification criteria and Doppler parameters for paravalvular regurgitation (PVR)
Transcatheter heart valves technologies
Abstract Background The Valve Academic Research Consortium 3 (VARC‐3) standardizes the classification criteria and Doppler parameters for paravalvular regurgitation (PVR)
Transcatheter heart valves technologies
Abstract Background The postoperative outcomes of transcatheter aortic valve replacement (TAVR) with the new generation of self-expanding valves (SEV) and
Transcatheter heart valves technologies
Abstract Background This study aims to develop a post-procedural risk prediction model for permanent pacemaker implantation (PPMI) in patients treated
Transcatheter heart valves technologies
Abstract Background We aim to determine predictors of inadequate left ventricular mass index (LVMi) regression at mid-term after transcatheter aortic
Transcatheter heart valves technologies
Abstract Symptomatic aortic valve stenosis (AS) and abdominal aortic aneurysm (AAA) are critical clinical conditions, increasingly more prevalent with aging
Transcatheter heart valves technologies
Abstract Background Transcatheter aortic valve implantation (TAVI) can either be conducted as an elective (scheduled in advance) or a non-elective
Transcatheter heart valves technologies
Abstract Background Post‐procedural aortic insufficiency (AI) continues to be prevalent following transcatheter aortic valve replacement (TAVR). While several studies have
Transcatheter heart valves technologies
Abstract Background Transcatheter aortic valve replacement (TAVR) is an increasingly used but relatively expensive procedure with substantial associated readmission rates.
Transcatheter heart valves technologies
Abstract Purpose/objectives Advancements in transcatheter mitral and tricuspid valve repair have resulted in growing demands in preprocedural computed tomography (CT)
Transcatheter heart valves technologies
Abstract Transcatheter mitral valve interventions (TMVI), either repair or replacement, are established alternative options for patients with mitral regurgitation (MR)